Ticker: DNLI

Company: Denali Therapeutics Inc.

Person: Ryan J Watts, director, officer

Transaction date: Jan. 6, 2026

Reporting date: Jan. 8, 2026

Average share price: 16.5

Sold 35198.0 shares for 580767.0